SAM
TEVA icon

Smithbridge Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Smithbridge Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-40,551
Closed -$1.35M – 78
2017
Q2 		$1.35M Buy
40,551
+4,281
+12% +$133K 1.11% 35
2017
Q1 		$1.16M Sell
36,270
-500
-1% -$17.1K 1.02% 39
2016
Q4 		$1.33M Buy
36,770
+30
+0.1% +$1.2K 1.18% 37
2016
Q3 		$1.69M Hold
36,740
– – 1.51% 34
2016
Q2 		$1.84M Hold
36,740
– – 1.71% 30
2016
Q1 		$1.97M Sell
36,740
-550
-1% -$32.3K 1.83% 27
2015
Q4 		$2.45M Sell
37,290
-200
-0.5% -$12.4K 2.25% 20
2015
Q3 		$2.12M Sell
37,490
-1,100
-3% -$71.3K 2.01% 25
2015
Q2 		$2.28M Buy
38,590
+250
+0.7% +$15.4K 1.92% 30
2015
Q1 		$2.39M Hold
38,340
– – 1.97% 25
2014
Q4 		$2.21M Hold
38,340
– – 1.8% 29
2014
Q3 		$2.06M Hold
38,340
– – 1.72% 31
2014
Q2 		$2.01M Sell
38,340
-13,100
-25% -$670K 1.69% 32
2014
Q1 		$2.72M Sell
51,440
-300
-0.6% -$13.9K 2.47% 22
2013
Q4 		$2.07M Sell
51,740
-1,400
-3% -$55.1K 1.9% 29
2013
Q3 		$2.01M Buy
53,140
+14,850
+39% +$579K 1.9% 29
2013
Q2 		$1.5M Buy
+38,290
New +$1.49M 1.52% 32

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Smithbridge Asset Management's TEVA Position: Q3 2017 in Review

Smithbridge Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 40,551 shares — an estimated $1.35M sold.

Smithbridge Asset Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $2.72M in Q1 2014. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Smithbridge Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Smithbridge Asset Management sold 40,551 Teva Pharmaceuticals shares in Q3 2017, an estimated $1.35M.
  • Smithbridge Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Smithbridge Asset Management's Teva Pharmaceuticals position peaked at $2.72M in Q1 2014.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Smithbridge Asset Management's 13F filing for Q3 2017, filed 12 Oct 2017.